NB02 (Poseltinib) combined rituximab and lenalidomide in R/ R PCNSL (POTENTIAL-P): Initial results of safety lead-in cohort.
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
NB02 (Poseltinib) combined rituximab and lenalidomide in R/ R PCNSL (POTENTIAL-P): Initial results of safety lead-in cohort.
저자
Yang, Deok-HwanOh, Sung YongJeon, YoungwooSong, Ga-YoungKim, SeokjinYoon, Sang EunKim, Tong-YoonLee, Ji HyunKim, Hye RyeonKoh, YoungilSong, HanLee, MyungseaKim, Won Seog
DOI
10.1182/blood-2025-5463
발행일
2025-11-03
유형
Meeting Abstract
저널명
Blood
146
페이지
5463 ~ 5464